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Abstract. To establish the time-sequence relationship be- 
tween ferritin accumulation and uroporphyrin crystal 
formation in livers of C57BL/10 mice, a biochemical, 
morphological and morphometrical study was per- 
formed. Uroporphyria was induced by the intraperi- 
toneal administration of hexachlorobenzene plus iron 
dextran and of iron dextran alone. Uroporphyrin crystal 
formation started in hepatocytes of mice treated with 
hexachlorobenzene plus iron dextran at 2 weeks and in 
mice treated with iron dextran alone at 9 weeks. In the 
course of time, uroporphyrin crystals gradually increased 
in size. Uroporphyrin crystals were initially formed in 
hepatocytes in the periportal areas of the liver, in which 
also ferric iron staining was first detected. The amount 
and the distribution of the main storage form of iron in 
hepatocytes, ferritin, did not differ between the two treat- 
ment groups. Ferritin accumulation preceded the forma- 
tion of uroporphyrin crystals in hepatocytes in both 
treatment groups. Moreover, uroporphyrin crystals were 
nearly always found close to ferritin iron. We conclude 
that uroporphyrin crystals are only formed in hepato- 
cytes in which also iron (ferritin) accumulates. Hexa- 
chlorobenzene accelerates the effects of iron in porphyrin 
metabolism, but does not influence the accumulation of
iron into the liver. 
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Introduction 
Both human and experimental uroporphyria are charac- 
terized by a partial block in the haem biosynthetic path- 
way at the level of uroporphyrinogen decarboxylase 
(URO-D; EC 4.1.1.37) and by the accumulation furo- 
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porphyrins and heptacarboxylporphyrins in the liver 
(Sweeney 1986). In C57BL/10 mice, uroporphyria can 
be induced by the administration f hexachlorobenzene 
(HCB), a polyhalogenated aromatic hydrocarbon 
(Marks 1985), and iron dextran as Imferon (IMF), but 
also by the administration of IMF alone (Smith and 
De Matteis 1990; Siersema et al. 1991). 
There is considerable evidence implicating iron in the 
pathogenesis of human and experimental uroporphyria 
(Sweeney etal. 1979; Smith and Francis 1983; Ferioli 
et al. 1984; Alleman et al. 1985; De Matteis 1988; Sierse- 
ma et al. 199J). In the experimental form, the action 
of iron may involve the catalysis of the highly reactive 
hydroxyl radical (OH.) (Aust and Svingen 1982; Halliw- 
el and Gutteridge 1985) or perhaps the production of 
reactive iron-oxygen species (Samokyszyn et al. 1988), 
which could react with uroporphyrinogen or another 
susceptible target o form an inhibitor of URO-D (Rios 
de Molina et al. 1980; Cantoni et al. 1984; Smith and 
Francis 1987). Alternatively, damage to URO-D either 
by a direct action of iron or by a free radical-mediated 
mechanism has been postulated (Mukerji et al. 1984). 
Recently, we observed in hepatocytes of porphyric 
mice a morphological co-occurrence of uroporphyrin 
crystals and iron (ferritin) and suggested a role for ferri- 
tin iron in the pathogenesis of uroporphyria (Siersema 
et al. 1991). This study was conducted at 18 weeks after 
treatment with HCB plus IMF and with IMF alone. 
At this time diffuse iron (as ferritin) and focal uropor- 
phyrin accumulation already existed. Therefore, we de- 
cided to perform biochemical, morphological (light mi- 
croscopical [LM], electron microscopical [EM]) and 
morphometrical studies in livers of C57BL/10 mice. We 
aimed to establish the time-sequence r lationship be- 
tween uroporphyrin crystal formation and ferritin iron 
accumulation at regular intervals from 1 week until 52 
weeks, after the intraperitoneal administration f HCB 
plus IMF and of IMF alone. 
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Materials and methods 
Chemicals 
HCB was purchased from Merck AG (Darmstadt, Germany), ferri- 
hydroxide-dextran complex in a 0.9% NaC1 solution (Imferon) 
was purchased from Fisons Pharmaceuticals (Vleusden, The Neth- 
erlands) and Avertin from Aldrich-Chemic GmBH & Co. (Stein- 
heim, Germany). All other chemicals were of the highest purity 
commercially available. 
Animals and treatment 
This study was performed according to the "Regulations for use 
of laboratory animals in the Erasmus University Rotterdam", laid 
down by the Laboratory Animal Committee of the Erasmus Uni- 
versity Rotterdam, The Netherlands. 
Male C57BL/10 mice, weighing 20 to 25 gm, were purchased 
from the Centraal Proefdier Bedrijf (Zeist, The Netherlands). The 
mice were divided into three groups: group I and 2 consisted each 
of 45 mice, and group 3 consisted of 9 mice. Mice in group 1 
were treated with 16 mg of HCB in two doses of 8 mg, on day 
1 and day 4. HCB was dissolved in 0.25 ml warm corn oil and 
injected intraperitoneally (i.p.). Mice in groups 1 and 2 were treated 
with IMF, 12 mg per mouse, also injected i.p. on day 1. Treatment 
was performed under anaesthesia with Avertin. Mice in group 3 
were not treated. At weekly intervals until week 15 and thereafter 
at weeks 20, 25, 30, 40 and 52, two mice of groups i and 2 were 
sacrificed for the morphological studies. In addition, at weeks 10, 
20, 30, 40 and 52 the biochemical measurements were performed 
in livers of 3 mice in groups 1 and 2. Three mice from group 
3 were sacrificed at weeks 0, 20 and 52 as controls for the morpho- 
logical studies and the same biochemical measurements. 
Under anaesthesia with Avertin, two liver lobes from the mice 
were removed for the measurement of the total porphyrin content 
and the total iron content. For the morphological studies, the por- 
tal vein was cannulated, and the liver was perfused with 3 % glutar- 
aldehyde in 0.14mol/1 cacodylate buffer, pH=7.4 (275 mOsm). 
A perfusion rate of 10 ml/min, a perfusion pressure of 15 cm Hg, 
and a perfusion temperature of 37 ~ C were maintained throughout 
the procedure. 
Measurement ofporphyrins 
For the measurement ofporphyrins inlivers, the lobes were homog- 
enized to yield a 10% homogenate in TRIS-HC1 buffer (50 mmol/1, 
pH = 8.0), which was centrifuged for 10 min at 1800 g. After freeze- 
drying and methylation the porphyrins in liver tissue were mea- 
sured by high pressure liquid chromatography as described earlier 
(Wilson et al. 1978; Siersema et al. 1991). Protein was measured 
according to Lowry et al. (1951). The amount of porphyrins was 
expressed in picomoles per milligram of protein. 
Total iron content 
This was determined using a modification of the method escribed 
by Harris (1978), which has been described previously (Siersema 
et al. 1991). The amount of iron was expressed as retool/100 gm 
dry weight. 
(with reduced water contact) (James et al. 1980), the ferric ferricya- 
nide reduction test in Li/lie's modification (Lillie and Fullmer 
1976), and Perls' Prussian-blue stain for ferric iron (Scbeuer et al. 
1962). For histological studies a Zeiss Axioplan microscope (Zeiss, 
Oberkochen, Germany) was used. 
For EM, small blocks were taken randomly from the perfused 
livers, dehydrated briefly through graded acetone series and embed- 
ded in Epon (Siersema et al. 1991). Ultrathin sections (60 nm) were 
collected on copper grids and examined with and without conven- 
tional staining (uranyl acetate and lead citrate) in a Zeiss EM 
902 transmission microscope (Zeiss, Oberkochen, Germany). This 
instrument is equipped with an integrated electron spectrometer 
allowing high-resolution imaging with energy-filtered lectrons [ = 
electron spectroscopic maging (ESI)]. For technical details, see 
Sorber et al. (1990a, b). 
Morphometrical nalysis 
This was performed as described in a previous report (Siersema 
et al. 1991). In brief, unstained Epon sections, 500- to 750 nm thick, 
were visualized by way of reflection-contrast microscopy, with the 
use of a Zeiss antiflex planneofluar, 63x/1.25, Ph3, oil-immersion 
objective (Fig. i) (Ploem 1975; Cornelese-ten Velde and Prins 
1990). Images were transferred to the image analyser IBAS 2000 
(Kontron/Zeiss, Munich, Germany) with a sensitive camera 
mounted on the Zeiss Axioplan microscope (Zeiss, Oberkochen, 
Germany). In sections of liver from each treatment group at the 
given time periods, 40 hepatocyte cytoplasmic areas of 8100 gm 2 
were randomly selected. The area fractions (expressed as percent- 
ages of the measured cytoplasmic frame area) of uroporphyrin 
crystals and ferritin particles present in each area were calculated. 
Grey-value frequency histograms were used for objective segmenta- 
tion and discrimination between ferritin and uroporphyrin crystals. 
For technical details, see Cleton et al. (1989) and Sorber et al. 
(1990a, b). 
Statistics 
Biochemical and morphometrical parameters in livers of the var- 
ious groups at the different ime intervals were tested for significant 
differences using the Wilcoxon's rank-sum test. The null hypothesis 
was rejected when p_> 0.05. 
Results 
Biochemistry 
Results of mean (_+S.D.) porphyr in content and mean 
(•  iron content in livers in the control group of 
mice and in mice treated with HCB plus IMF  and IMF  
alone at different times are given in Table 1. As can 
be seen from this table, up to week 30, porphyr in content 
in mice treated with HCB plus IMF  was significantly 
more increased as compared with mice treated with MF  
alone. Thereafter, no significant difference in the in- 
crease in porphyr in content was observed between the 
two treatment groups. Throughout  the whole study peri- 
od, i ron content was not different between mice treated 
with HCB plus IMF  and mice treated with IMF  alone. 
LM and EM studies 
For LM, a part of the perfused liver was dehydrated briefly through 
graded alcohol series, embedded inparaffin, serially sectioned and 
stained. The staining protocol included Gill's hematoxylin stain 
Light microscopy 
The lobular architecture of the livers from mice treated 
with HCB plus IMF  and IMF  alone remained intact 
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Fig. 1. Reflection-contrast micro- 
graph of an unstained Epon sec- 
tion of mouse liver tissue, 20 
weeks after treatment with iron 
dextran, showing uroporphyrin 
crystals (arrowheads) and ferritin 
particles (arrows). x 500 
Fig. 2. Light micrograph, Perls' 
Prussian-blue stain of mouse liver 
tissue, 2 weeks after treatment 
with hexachlorobenzene and iron 
dextran. Note staining (indicating 
ferric iron) in the (peri)portal and 
midzonal areas of the liver. PT  
Portal tract; CV central vein. x 25 
Fig. 3. Light micrograph, Perls' 
Prussian-blue stain of mouse liver 
tissue, 5 weeks after treatment 
with hexachlorobenzene and iron 
dextran. Note staining (indicating 
ferric iron) in the (peri)portal and 
the centrilobular areas of the 
liver. PT  Portal tract; CV central 
vein. x 50 
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Table 1. Biochemical data of liver tissue in control mice and in 
mice treated with HCB and IMF, and with IMF alone. HCB, 
hexachlorobenzene; IMF, iron dextran; .d., not done 
Parameter Duration Controls Treatment groups 
of study 
(weeks) HCB + IMF IMF 
Porphyrin content" 
Iron content b 
0 2.0_+0.5 n.d. n.d. 
10 n.d.  198• ~ 60_+11 
20 1.8_+0.4 391 • ~ 212__+42 
30 n.d.  498+_65 ~ 345+_68 
40 n.d.  543_+101 d 459_+98 
52 2.1+_0.5 69• d 524+-112 
0 0.3_+0.2 n.d. n.d. 
10 n.d. 4.9+_0.6 d 4.7• 
20 0.4__+0.2 11.2_+0.9 d 11.6_+1.1 
30 n .d .  12.9+1.2 a 13,3+_1.4 
40 n.d. 10.5_+1.1 d 9.9-+1.3 
52 0.4_+0.2 9.2• 1.0 d 9.4___1.2 
" mean (• in pmol per mg protein; 
b mean (• in mmol/100 gm dry weight; 
~ P<0.05 compared with IMF group; 
d HCB + [MF group not different from IMF group 
during the experimental period, i.e., the portal tracts 
did not show evidence of inflammatory infiltration or 
fibrosis. In addition, there was no liver cell necrosis in 
the lobular areas of the liver. At 3 weeks, the nuclei 
of the hepatocytes in both treatment groups appeared 
somewhat enlarged and some nuclei contained up to 
three nucleoli as compared with mice that were not treat- 
ed. This was more pronounced in mice treated with HCB 
plus IMF than in mice treated with IMF alone. Concern- 
ing the aim of this study we did not further quantify 
this difference. In livers of mice treated with HCB, there 
was a patchy distribution of lipid droplets in the hepato- 
cytes. This later finding can be attributed to the fact 
that HCB was dissolved in corn oil (Siersema et al. 1991). 
During the whole period of the study, the pattern 
of iron deposition was not different between livers of 
mice treated with HCB plus IMF and with IMF alone. 
Immediately after the administration of IMF, iron-posi- 
tive granules were observed in Kupffer cells. Thereafter, 
the amount of iron-positive granules in Kupffer cells 
increased and many of these cells became enlarged. 
Moreover, aggregates of iron-loaded macrophages (" si- 
derophages") were formed. Initially, iron-loaded 
Kupffer cells were distributed iffusely throughout the 
liver lobules. By the 2nd week, iron-loaded Kupffer cells 
were observed to accumulate in the portal and per• 
areas, but also spreading to the midzonal areas of the 
liver lobule (Fig. 2). By the 5th week, both Kupffer cells 
and siderophages, occurring singly or in small groups, 
were also noted in the centrilobular areas of the liver 
(Fig. 3). By the 2nd week, iron-positive granules were 
noted in hepatocytes, initially located close to the portal 
areas, but soon spreading to the midzonal areas of the 
Fig. 4. Electron micrograph of a mouse hepatic parenchymal cell, 
6 weeks after treatment with iron dextran. S Siderosome (iron- 
containing lysosome); FCI ferritin cluster; CpF cytoplasmic ferri- 
tin; M mitochondrion. Electron-spectroscopic image (ESI) of un- 
stained section. Bar: 0.6/xm 
Fig. 5. Electron micrograph of a mouse hepatic parenchymal cell, 
6 weeks after treatment with hexachlorobenzene plus iron dextran. 
UP Uroporphyrin crystal; FV ferritin-containing vacuole; L lipid 
droplet. Electron-spectroscopic image (ESI) of unstained section. 
Bar: 0.6 gin 
liver lobule (Fig. 2). In the course of time, iron-positive 
staining in hepatocytes xtended iffusely through the 
liver towards the centrilobular eas of the liver (Fig. 3). 
By week 6, siderosis of the liver was graded as massive 
[grade 4 according to Scheuer et al. (1962)]. After 52 
weeks, Kupffer cells and siderophages, but also hepato- 
cytes in the liver lobule still displayed a positive iron 
reaction. At this time, the highest concentration f iron- 
positive granules eemed to be present in the periportal 
areas. 
Uroporphyrin crystals were first noted in hepatocytes 
of mice treated with HCB plus IMF by the 2nd week. 
The first uroporphyrin crystals were observed in those 
hepatocytes in which the first iron deposits were also 
detected, i.e., in the periportal areas of the liver (Fig. 1). 
The first uroporphyrin crystals were observed in hepato- 
cytes of mice treated with IMF alone at the 9th week. 
During the entire study period, however, in both treat- 
ment groups uroporphyrin crystals were not regularly 
distributed but were usually found in those hepatocytes, 
in which also the highest concentrations of iron-positive 
granules were present, i.e., in the periportal areas and 
later also, although to a lesser degree, in the centrilobu- 
lar areas of the liver. 
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Electron microscopy 
Iron overload in hepatocytes of both treatment groups 
was initially seen as an increase and clustering of cyto- 
plasmic ferritin. In addition, from 2 weeks onwards, fer- 
ritin was also found in siderosomes (iron-containing ly- 
sosomes) in hepatocytes (Fig. 4). At 6 weeks, the cellular 
organelles showed the characteristic signs of iron over- 
load: indented heterochromatic nuclei, swollen endo- 
plasmic reticulum, widened intercellular spaces some- 
times containing collagen fibers, and flattened microvilli 
in the bile canalicular region. Apart from an increased 
amount of lipid droplets in hepatocytes of mice treated 
with HCB (which was dissolved in corn oil), no differ- 
ence was observed in the ultrastructure between mice 
treated with HCB plus IMF and with IMF alone during 
the experimental period. Moreover, there was no differ- 
ence in the pattern of distribution and in the storage 
forms of iron between hepatocytes of mice treated with 
HCB plus IMF and with IMF alone. 
Uroporphyrin crystals in hepatocytes could be exam- 
ined best in unstained Epon sections. Uroporphyrin 
crystals were randomly located in hepatocytes close to 
ferritin (Figs. 5, 6). Throughout the study period, it ap- 
peared that uroporphyrin crystals gradually increased 
in size (Figs. 5, 6). 
Morphometrical nalysis 
The results of the morphometrical nalysis in hepato- 
cytes of mice treated with HCB plus IMF and with IMF 
alone are shown in Figs. 7, 8. As can be seen from these 
figures, the area fractions of ferritin in hepatocytes at
the various time intervals were not different between 
Fig. 6. Electron micrograph ofa mouse hepatic parenchymal ce l, 
18 weeks after treatment with hexachlorobenzene plus iron dextran. 
Note close association between uroporphyrin crystal (UP) and fer- 
ritin (arrows). FV Ferritin-containing vacuole. Electron-spectros- 
copic image (ESI) of unstained section. Bar: 0.6 p-m 
mice treated with HCB plus IMF or with IMF alone. 
Up to 20 weeks, there was a steep increase in the area 
fractions of ferritin (HCB plus IMF: Y=0.13X+0.07; 
IMF: Y=0.13X+0.05). Thereafter, area fractions of 
ferritin gradually decreased in both treatment groups. 
In the course of time, area fractions of uroporphyrin 
crystals gradually increased in both treatment groups. 
Up to 30 weeks, area fractions of uroporphyrin crystals 
were significantly different between mice treated with 
HCB plus IMF and IMF alone. At weeks 40 and 52, 
however, area fractions of uroporphyrin crystals were 
not different between the two treatment groups. 
In Fig. 9 the mean ratios between the area fractions 
of uroporphyrin crystals and area fractions of ferritin 
particles at different ime intervals are presented: this 
has been called the 'porphyrins per ferritin area fraction 
ratio'. As can be seen from this figure, from 2 weeks 
up to 20 weeks in hepatocytes ofmice treated with HCB 
plus IMF, these ratios were relatively constant, i.e., be- 
tween 0.2 and 0.3. In contrast, by the 9th week in hepato- 
cytes of mice treated with IMF alone, the porphyrins 
per ferritin area fraction ratios became positive at a 
lower level and increased in the course of time. By the 
20th week, there was a similar and sustained increase 
in both treatment groups in the porphyrins per ferritin 
area fraction ratios in the course of time (HCB plus 
IMF: Y-0.004X+0.208; IMF: Y=0.004X+0.118). 
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Fig. 7. Morphometrical nalysis by reflection-contrast microscopy 
of unstained Epon sections howing area fractions of uroporphyrin 
crystals (Porphyrins) and of ferritin particles (Ferritin) at different 
time intervals in livers of mice treated with hexachlorobenzene 
plus iron dextran (HCB + IMF group). For the period up to 
20 weeks, the calculated regression lines of the area fraction in- 
crease for uroporphyrin crystals and for ferritin particles are indi- 
cated 
Fig. 8. Morphometrical nalysis by reflection-contrast microscopy 
of unstained Epon sections howing area fractions of uroporphyrin 
crystals (Porphyrins) and of ferritin particles (Ferritin) at different 
time intervals in livers of mice treated with iron dextran alone 
(IMF group). For the period up to 20 weeks, the calculated regres- 
sion lines of the area fraction increase for uroporphyrin crystals 
and for ferritin particles are indicated 
Fig. 9. Morphometrical nalysis by reflection-contrast microscopy 
of unstained Epon sections howing ratios of porphyrins per ferri- 
tin area fractions at different ime intervals in livers of mice after 
treatment with iron dextran (IMF group) and after treatment with 
hexachlorobenzene plus iron dextran (HCB + IMF group). For 
the period from 20 weeks up to 52 weeks, the calculated regression 
lines of the ratio of porphyrins per ferritin area fractions in both 
treatment groups are indicated 
In comparing the ratios between the morphometri- 
cally determined amount of uroporphyrin crystals and 
of ferritin particles with the ratios between the biochemi- 
cally determined porphyrin content and the iron content 
in livers, an identical pattern was observed in the two 
treatment groups (results not shown). 
Discussion 
In accordance with earlier findings, we confirmed that 
the intraperitoneal dministration of HCB plus IMF, 
but also of IMF alone to C57BL/10 mice resulted in 
a time-dependent accumulation furoporphyrin crystals 
in the liver. In addition, we have previously found that 
HCB alone, without concomitant IMF administration, 
does not produce (uro)porphyria n this strain of mice 
(Siersema et al. 1991). In the course of time, uroporphy- 
rin crystals gradually increased in size in both treatment 
groups (Figs. 5, 6). We have found that in areas where 
uroporphyrin crystals are present, fluorescence of sur- 
rounding intracytoplasmic porphyrins can be observed 
as well (Siersema et al. 1991). Therefore, it seems likely 
that the enlargement of uroporphyrin crystals in the 
course of time is caused by the synthesis and apposition 
from surrounding porphyrins. 
Our data on iron distribution in liver after adminis- 
tration of IMF are in agreement with observations by 
others, in that iron-positive staining initially was de- 
tected in Kupffer cells and siderophages, followed by 
the presence of ferric iron in hepatocytes in both treat- 
ment groups (Fig. 2) (Goldberg et al. 1957; Dunn 1967; 
Pechet 1969; Van Wyk et al. 1971; Hultcranz and Ar- 
borgh 1978; Parmley et al. 1981; Smith et al. 1990). The 
main storage form of iron in both treatment groups was 
ferritin. Morphometrically, no difference in the amount 
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of ferritin was observed between hepatocytes of mice 
treated with HCB plus IMF  and with IMF alone 
(Figs. 7, 8). In addition, at the ultrastructural level, the 
distribution pattern of ferritin was not different between 
the two treatment groups. Therefore, it can be concluded 
that HCB by itself did not influence the iron accumula- 
tion into the liver. 
The formation of uroporphyrin crystals developed 
more rapidly in livers of mice treated with HCB plus 
IMF  than in mice treated with IMF alone, suggesting 
an active role for HCB in the process of uroporphyrin 
formation. Moreover, the morphometrical nalysis re- 
vealed that for the formation of uroporphyrin crystals 
in hepatocytes of mice treated with IMF  alone (as com- 
pared with mice treated with HCB plus IMF) much more 
iron (ferritin) needed to be accumulated before uropor- 
phyrin crystal formation was initiated (Fig. 9). 
HCB has been demonstrated to induce a particular 
isoenzyme of the cytochrome P-450 complex in the liver, 
cytochrome P-4501a2, leading to the uncoupling of the 
microsomal system in the liver (Jacobs et al. 1989). Sub- 
sequently, reactive oxygen species are formed (Ferioli 
et al. 1984; Sweeney et al. 1984; Smith and Francis 1987; 
Sinclair et al. 1987; De Matteis et al. 1988). I f  " f ree"  
iron is present, either the highly reactive hydroxyl radical 
(OH-) (Aust and Svingen 1982; Halliwel and Gutteridge 
1985) and/or reactive iron-oxygen species (Samokyszyn 
et al. 1988) are produced, which could react with uropor- 
phyrinogen or another susceptible target to form an 
URO-D inhibitor (Rios de Molina et al. 1980; Cantoni 
et al. 1984; Smith and Francis 1987). This explains the 
accumulation of uroprophyrin crystals in hepatocytes 
(Smith et al. 1990). Alternatively, damage to URO-D 
either by a direct action of iron or by a free radical- 
mediated mechanism has been postulated (Mukerji et al. 
1984). Since uroporphyria lso developed in mice treated 
with IMF  alone, induction of the cytochrome P-450 sys- 
tem by HCB is not an absolute requirement. Smith et al. 
(1990) have suggested that in hepatocytes of C57BL/10 
mice a genetically determined active oxidative metabo- 
lism is present, which could explain that, after adminis- 
tration of IMF alone, uroporphyria develops at a slower 
rate (Figs. 7, 8). 
A common denominator in all these theories is the 
presence of ferrous iron in hepatocytes. Intracellular fer- 
rous iron, however, is mainly sequestered in ferritin in 
hepatocytes of C57BL/10 mice (Siersema et al. 1991) and 
is as such not likely to induce OH-production. The re- 
lease of iron from ferritin requires reduction (Munro 
and Linder 1978). Although in vitro release of ferrous 
iron from ferritin by liver microsomes has been described 
(Rowley and Sweeney 1984; Samokyszyn etal. 1988; 
De Matteis et al. 1988), it is not clear whether this also 
occurs in vivo. It has been suggested that a small fraction 
of intracellular iron is bound to a variety of molecules 
of low molecular weight (LMW) (Jacobs 1977). Th is  
pool of LMW iron is thought to be more readily avail- 
able for a catalytic role in the Haber-Weiss cycle. More- 
over, a role for LMW iron has been demonstrated in
the process of free radical formation in iron-loaded cells 
(Voogd et al. 1992). Therefore, a study is now in pro- 
gress, using a recently developed technique (Voogd et al. 
1992), to measure the amount of LMW iron in tissue 
homogenates to further elucidate this problem. 
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